A new diagnosis
Seek review of available pathology, imaging and an existing treatment proposal.
Cancer Care / Shanghai
Understand the sequence. Keep the next step connected.
Cancer care can involve several treatments, teams and locations. We help organize what has already happened, what the doctors are proposing and how the next stage could be coordinated between Shanghai and home.
Start with a free HSMC meeting. Specialist medical review is a separate paid service.
Care concerns
Where are you in the treatment journey?
Surgical decisions
Bring questions about a proposed operation to the relevant specialist team.
Further options after prior treatment
Ask about a review of the treatment history and questions for the next stage.
Care involving several specialties
Coordinate relevant specialist input where it is included in the confirmed review scope.
Targeted therapy & biomarker review
Ask the oncology team whether existing results or further assessment could inform targeted treatment choices.
Explore treatment options ↗Innovative medicines & trial opportunities
Explore whether the team identifies relevant approved medicines or research opportunities, with access and eligibility confirmed separately.
Explore treatment options ↗YOUR SPECIALIST CARE PATHWAY
Understand the history. Decide the next stage. Connect care across borders.
The value of an additional opinion lies in how it helps clarify the whole pathway: what has happened, what is proposed next and how the stages fit together.
01 Reconstruct the Treatment History
Give the reviewing team a coherent view of previous assessments, treatments and available response records.
02 Clarify the Next Treatment StageExplore the proposed sequence and the purpose of each stage, including further options when clinically relevant.
03 Connect Shanghai and Local CareA care plan may involve different places and several stages. Define who is responsible for each agreed part.
01
Reconstruct the Treatment History
Give the reviewing team a coherent view of previous assessments, treatments and available response records.
Questions to clarify
Are the relevant pathology, imaging and treatment details available? What does the team need to understand before discussing another option?
The clinical team
The reviewing specialists interpret the clinical information and identify any additional pathology, investigations or records needed for their assessment.
HSMC coordination
We organize available records by date and treatment stage, record missing items requested by the team and coordinate the authorized review.
What we help bring together
A treatment chronology and an agreed list of outstanding information for the review.
02
Clarify the Next Treatment Stage
Explore the proposed sequence and the purpose of each stage, including further options when clinically relevant.
Questions to clarify
What is the next decision? Which specialties should contribute, what must be confirmed first, and how do the recommendations fit together?
The clinical team
The clinical teams make treatment recommendations. Questions about advanced therapies or trials are assessed in context; suitability, availability and eligibility are determined by the hospital or trial team.
HSMC coordination
We bring the doctors’ advice together, coordinate another team where useful and agreed, and help clarify the proposed sequence, practical requirements and preliminary cost estimates.
What we help bring together
A next-stage decision summary: medical recommendations, unresolved dependencies and the proposed care arrangements.
03
Connect Shanghai and Local Care
A care plan may involve different places and several stages. Define who is responsible for each agreed part.
Questions to clarify
Which stages are proposed in Shanghai? Could any continue locally, who would provide them and how will the teams exchange records?
The clinical team
The treating teams and an accepting local clinician determine whether local care is appropriate and available. Future treatment and follow-up are clinical decisions.
HSMC coordination
We coordinate the agreed Shanghai episode, authorized handover and confirmed onward communication. Later cycles, return visits and continuing coordination are included only if specified in the written case scope.
What we help bring together
A defined care-stage and handover plan: hospitals, responsibilities, agreed endpoint and available onward-care information.
The items above are confirmed within your chosen service and written scope; they are not all included in appointment-only support. Medical decisions remain with the clinicians.
Relevant specialist input
Relevant input may come from medical oncology, surgery, radiation oncology, pathology or imaging. We confirm the teams needed for the specific decision; a formal multidisciplinary review requires its own confirmed arrangement.
One case does not automatically include every future treatment, return trip or follow-up. These are included only where specified in the written scope. Treatment response and trial enrollment cannot be guaranteed.
ADDITIONAL SPECIALIST OPTIONS
Targeted Therapy, Innovative Medicines & Clinical Trials
Ask the oncology team whether your pathology, available biomarker results and treatment history suggest further drug options. We help clarify the clinical questions and practical access requirements for the proposed pathway in China.
Targeted treatment options
The oncologist reviews available molecular or biomarker findings and decides whether a targeted therapy or additional testing is relevant. A detected marker does not guarantee a suitable or effective treatment.
Innovative medicine opportunities
Discuss medicines the team considers relevant, including whether a proposed option is approved for your indication or investigational. The hospital confirms local availability, access requirements and estimated charges.
Clinical trial exploration
Where appropriate, we coordinate an inquiry about potentially relevant studies. The trial team determines current recruitment, eligibility and enrollment. This is distinct from access to an approved treatment.
HSMC coordinates information, hospital communication and agreed access inquiries; physicians prescribe and hospitals provide treatment. No drug access, trial enrollment or treatment benefit is guaranteed.
Background reading: NCI · Biomarker testing · NCI · Targeted therapy
Useful records for this specialty
Tell us what is available.
We confirm authorization, recipients and the submission route before you share medical documents. The team may request additional information.
- Pathology reports and available biomarker results
- Recent imaging reports and original images
- Dated treatment history, including drugs, surgery and radiation
- Current care plan, medicines and the questions you want reviewed
Questions specific to this care pathway.
Can you organize a review after several previous treatments?
Yes, subject to the team accepting the review. A dated treatment history is particularly useful. We confirm the question, team and scope before the paid review begins.
Can part of my treatment continue locally?
This must be discussed with the treating teams and a local clinician willing and able to provide the care. We can coordinate communication where agreed; local treatment availability is not assumed.
Does a review guarantee access to a new therapy or trial?
No. It may clarify current recommendations or explore alternatives. Clinical suitability, trial eligibility, availability and acceptance remain with the relevant hospital or trial team.
Can I ask about targeted therapy or innovative medicines?
Yes. The oncology team considers your diagnosis, available biomarkers and treatment history. We help clarify proposed options, current availability and whether access would be through approved care or a research study.